将基于证据的指导方针转化为临床决策支持工具,以改善家族高胆固醇血清症的识别和管理
Timothy C Shuey1, Tyler J Schubert2,3, Katrina Romagnoli4
1Department of Internal Medicine, Geisinger Medical Center, Danville, PA.
概括
在电子健康记录中实施临床决策支持工具可以改善家族性高胆固醇血症 (FH) 的护理. 这项研究使用实施科学来开发和完善基于临床医生的反的工具,提高准则的遵守.
科学领域:
- 医疗信息学 医疗信息学
- 实施科学 实施科学
- 临床决策支持 临床决策支持
背景情况:
- 基于证据的临床指南对于决策至关重要,但面临实施挑战.
- 家族性高胆固醇血症 (FH) 是一种显著的临床疾病,突出了指导方针和实践之间的差距.
- 需要有效的实施策略,以将指南纳入常规护理.
研究的目的:
- 为家族性高胆固醇血症 (FH) 设计和开发嵌入电子健康记录 (EHR) 的临床决策支持工具.
- 通过实施科学方法,改进高风险的成人和儿科患者的护理.
- 纳入最终用户的反,以改进用于更好的临床实践的工具.
主要方法:
- 利用实施科学方法来创建EHR集成的工具,包括FH智能套件和临床笔记模板.
- 通过直接观察,半结构面试和深思熟虑的参与会议收集最终用户反.
- 代开发和试点测试的工具,在初始部署之前和之后结合临床医生的见解.
主要成果:
- 临床医生表示需要全面的,基于指导方针的工具来支持协作护理.
- 试点测试揭示了初始工具代的技术问题.
- 最终用户建议持续进行检查,以持续监测和改进.
结论:
- 实施科学方法和最终用户反在开发实用的临床决策支持工具方面是有效的.
- 开发的EHR工具可以帮助弥合落实FH基于证据的指导方针的差距.
- 这种方法提供了一个可扩展的解决方案,用于克服医疗保健机构采用指南的障碍.
相关概念视频
01:26Atherosclerosis III: Management
44
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
44
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
900
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
900
01:26Coronary Artery Disease IV: Preventive Measures
41
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
41
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
49
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
49
01:18Lipids: Dietary Sources and Requirements
1.1K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.1K
01:30Coronary Artery Disease I: Introduction
70
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
70